Skip to main content
Premium Trial:

Request an Annual Quote

Analyst Begins Covering Fisher, Says Record of Growth Warrants Outperform Rating

NEW YORK, June 3 (GenomeWeb Daily News) - An analyst for Leerink Swann  initiated coverage of Fisher Scientific, and has given the company an 'Outperform' rating, the investment bank said today.

 

John Sullivan, senior biotechnology and life sciences analyst for Leerink Swann said Fisher's "record of internal and acquired growth, the expansion of its strong franchise in life science consumables, and its strategy of adding higher margin products to its mix" fueled his decision.

 

Fisher acquired  proteomics shop Perbio in 2003 and  RNAi tools provider Dharmacon one year later. As GenomeWeb News reported last week, the company said it is eyeing potential acquisitions as it continues to look for ways to grow its footprint in the life-sciences market.

 

Fisher said it is focusing on higher-growth consumables plays in the molecular biology tools field, Vice Chair Paul Meister said during a recent investor conference.

 

He said Fisher expects $400 million in cash flow this year, which would ensure the company is flexible for any potential acquisition targets that come its way.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.